Nath Bio-Genes (India) Limited announced board approval for the re-appointment of Mr. Hitesh Rajnikant Purohit as an Independent Director for a five-year term. Additionally, M/s. K.P. Sahasrabudhe and Co was appointed as the Internal Auditor for a 12-month tenure starting May 4, 2026.
Nath Bio-Genes (India) Limited has scheduled a board meeting on May 4, 2026, to consider audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The board will also consider recommending a final dividend for the financial year. The trading window remains closed until May 6, 2026.
Nath Bio-Genes (India) Ltd will hold a Board Meeting on May 4, 2026. The board will consider audited financial results for Q4 and FY26, alongside a dividend recommendation for 2025-26. The trading window remains closed until May 6, 2026.
